ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychologist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,367Medicare Part D Prescriptions Filled, Including Refills
$1.33M Total Retail Price of All Prescriptions
417 Patients Receiving at Least One Drug in Part D
11%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
BENZTROPINE MESYLATE 691 73 R
CITALOPRAM HBR 525 15
TRAZODONE HCL 422 24
RISPERIDONE 390 24
BUSPIRONE HCL 333 41
QUETIAPINE FUMARATE 324 38
DOXEPIN HCL 318 21
ABILIFY 304 28
DIVALPROEX SODIUM ER 287 15
MIRTAZAPINE 257 19
OLANZAPINE 236 36
CLOZAPINE 216 0
SERTRALINE HCL 209 34
INVEGA SUSTENNA 200 0
FLUOXETINE HCL 187 31
CYMBALTA 181 0
LAMOTRIGINE 180 0
RISPERDAL CONSTA 166 0
HALOPERIDOL 165 24
INVEGA 147 24
ZIPRASIDONE HCL 136 0
LITHIUM CARBONATE 126 0
ZOLPIDEM TARTRATE 126 0
PAROXETINE HCL 118 30
HALOPERIDOL DECANOATE 112 12
SEROQUEL 111 11
VENLAFAXINE HCL ER 104 0
LATUDA 94 0
TRIHEXYPHENIDYL HCL 88 0 R
ESCITALOPRAM OXALATE 78 18
ZYPREXA 74 20
ROPINIROLE HCL 68 0
GABAPENTIN 66 0
DIVALPROEX SODIUM 62 0
CLOMIPRAMINE HCL 61 0 R
OXCARBAZEPINE 61 0
BUPROPION XL 60 0
HYDROXYZINE PAMOATE 58 0 R
SEROQUEL XR 54 0
FLUPHENAZINE HCL 54 0
BUPROPION HCL SR 53 0
DONEPEZIL HCL 50 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.